| | | Single nucleotide variant (missense variant) | Congenital myopathy 18 +5 more | |
| | | Single nucleotide variant (missense variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +5 more | |
| | | Single nucleotide variant (missense variant) | not provided +5 more | |
| | | Single nucleotide variant (missense variant) | Hypokalemic periodic paralysis, type 1 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hypokalemic periodic paralysis, type 1 +5 more | |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (missense variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +5 more | |
| | | Single nucleotide variant (missense variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +5 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +5 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Congenital myopathy 18 +5 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Hypokalemic periodic paralysis, type 1 +4 more | |
| | | Single nucleotide variant (intron variant) | Hypokalemic periodic paralysis, type 1 +5 more | |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | |
| | | Single nucleotide variant (synonymous variant) | Hypokalemic periodic paralysis, type 1 +2 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 5 +5 more | |
| | | Single nucleotide variant (synonymous variant) | Hypokalemic periodic paralysis, type 1 +1 more | |
| | | Single nucleotide variant (intron variant) | not provided +5 more | |
| | | Single nucleotide variant (intron variant) | Congenital myopathy 18 +5 more | |
| | | Single nucleotide variant (synonymous variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +3 more | |
| | | Single nucleotide variant (synonymous variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | |
| | | Single nucleotide variant (synonymous variant) | Hypokalemic periodic paralysis, type 1 +3 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Malignant hyperthermia, susceptibility to, 5 +3 more | |
| | | Single nucleotide variant (synonymous variant) | Congenital myopathy 18 +5 more | |
| | | Single nucleotide variant (missense variant) | isoflurane response - Toxicity +6 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Hypokalemic periodic paralysis, type 1 +1 more | |
| | | Single nucleotide variant (missense variant) | Hypokalemic periodic paralysis, type 1 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Hypokalemic periodic paralysis, type 1 +4 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +3 more | |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 | |
| | | Single nucleotide variant (synonymous variant) | Hypokalemic periodic paralysis, type 1 +5 more | |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 5 +5 more | |
| | | Single nucleotide variant (intron variant) | not specified +5 more | |
| | | Single nucleotide variant (synonymous variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +5 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hypokalemic periodic paralysis, type 1 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +5 more | |
| | | Single nucleotide variant (synonymous variant) | Congenital myopathy 18 +5 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +3 more | |
| | | Single nucleotide variant (intron variant) | Malignant hyperthermia, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (intron variant) | Malignant hyperthermia, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (intron variant) | Hypokalemic periodic paralysis, type 1 +4 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Hypokalemic periodic paralysis, type 1 +5 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +5 more | |
| | | Single nucleotide variant (intron variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | |
| | | Single nucleotide variant (missense variant) | Congenital myopathy 18 +5 more | |
| | | Single nucleotide variant (missense variant) | Hypokalemic periodic paralysis, type 1 +5 more | |
| | | Single nucleotide variant (synonymous variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +5 more | |
| | | Single nucleotide variant (missense variant) | not provided +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 5 +5 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 | |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 5 +3 more | |
| | | Single nucleotide variant (synonymous variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +5 more | |
| | | Single nucleotide variant (missense variant) | Hypokalemic periodic paralysis, type 1 +5 more | |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 5 +3 more | |
| | | Single nucleotide variant (synonymous variant) | not specified +5 more | |
| | | Single nucleotide variant (synonymous variant) | Congenital myopathy 18 +5 more | |
| | | Single nucleotide variant (intron variant) | Hypokalemic periodic paralysis, type 1 +1 more | |
| | | Single nucleotide variant (intron variant) | Malignant hyperthermia, susceptibility to, 5 +1 more | |
| | | Indel (missense variant) | Malignant hyperthermia, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (missense variant) | Hypokalemic periodic paralysis, type 1 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 5 +3 more | |
| | | Single nucleotide variant (missense variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Malignant hyperthermia, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 | |
| | | Single nucleotide variant (synonymous variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (missense variant) | Hypokalemic periodic paralysis, type 1 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Hypokalemic periodic paralysis, type 1 +5 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Congenital myopathy 18 +5 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 5 +3 more | |
| | | Single nucleotide variant (intron variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | |
| | | Single nucleotide variant (synonymous variant) | not specified +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | desflurane response - Toxicity +6 more | |
| | | Single nucleotide variant (missense variant) | Hypokalemic periodic paralysis, type 1 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Hypokalemic periodic paralysis +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not specified +5 more | |
| | | Single nucleotide variant (5 prime UTR variant) | not provided +2 more | GConflicting classifications of pathogenicity |